首页> 外文期刊>Canadian Urological Association Journal >Laparoscopic nephroureterectomy in a patient with a left ventricular assist device
【24h】

Laparoscopic nephroureterectomy in a patient with a left ventricular assist device

机译:带左心室辅助装置的患者的腹腔镜肾结直肠切除术

获取原文
           

摘要

Left ventricular assist device (LVAD) therapy is an established treatment option for select patients with advanced heart failure. Advances in technology and patient management have resulted in improved post-implant outcomes. Consequently, more patients with LVADs are presenting for evaluation and care of non-cardiac surgical disease. However, there is a paucity of literature regarding the optimal perioperative and surgical management of such patients. We present the case of a 71-year-old male with a HeartMate II (Thoratec Corporation, Pleasanton, CA) LVAD, who underwent a laparoscopic left nephroureterectomy for an upper urinary tract transitional cell carcinoma. His perioperative course was uneventful due to the multidisciplinary efforts of cardiac surgery, cardiac anesthesia, nephrology and urology. To our knowledge, this is the first reported case of a laparoscopic nephroureterectomy in a patient with a HeartMate II LVAD.
机译:左心室辅助装置(LVAD)治疗是某些晚期心力衰竭患者的既定治疗选择。技术和患者管理的进步已导致植入后效果的改善。因此,越来越多的LVAD患者正在接受评估和护理非心脏外科疾病。但是,关于这类患者最佳的围手术期和手术治疗的文献很少。我们介绍了一个患有HeartMate II(Thoratec Corporation,Pleasanton,CA)LVAD的71岁男性病例,该患者接受了腹腔镜左肾结膜切除术治疗上尿路移行细胞癌。由于心脏手术,心脏麻醉,肾病学和泌尿科的多学科努力,他的围手术期顺利进行。据我们所知,这是第一例报道了HeartMate II LVAD患者的腹腔镜肾切除术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号